Suppliers

PRA Health Sciences

PRA Health Sciences

PRA is a global drug development partner providing strategies and solutions spanning every stage of asset development. Today, we are consistently ranked among the top CROs and best employers in the world, all while striving to reinvent healthcare research tomorrow.

PRA helps develop lifesaving and life-improving drugs with our comprehensive clinical development services, including data management, statistical analysis, clinical trial management, medical writing, and regulatory and drug development consulting. We’re committed to leveraging our expertise and cutting-edge technology in order to expand the possibilities of traditional clinical drug development – and beyond. 

Latest content from PRA Health Sciences

Related resources

Parents as Gatekeepers for Children with Cancer

Parents as Gatekeepers for Children with Cancer

Content provided by PRA Health Sciences | 08-Jun-2020 | White Paper

The RACE for Children Act will require new drugs intended for adult cancer treatment to also be studied in pediatric cancers when the molecular target...

RACE Act Prompts Pediatric Oncology Trials

RACE Act Prompts Pediatric Oncology Trials

Content provided by PRA Health Sciences | 04-May-2020 | White Paper

Many providers prescribe drugs off-label to pediatric patients, even though there have been few pediatric trials for many of these drugs. In response,...